Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate

Conditions:   Head and Neck Squamous Cell Carcinoma;   Margin Assessment
Intervention:   Drug: Cetuximab-IRDye800CW
Sponsors:   University Medical Center Groningen;   UMC Utrecht;   Erasmus Medical Center, Rotterdam
Not yet recruiting - verified April 2017

http://ift.tt/2pOLCQI